Lupin receives approval from USFDA for Emtricitabine and Tenofovir Alafenamide Tablets
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
This product would be manufactured at Lupin's Nagpur facility in India
DETAF would be a welcome new addition in the management of HIV infections and will be available for supplies to low- and middle-income countries
Through this agreement, Lupin will introduce two new formulations, a fixed-dose combination of Rifapentine + Isoniazid and Rifapentine 300 mg standalone tablets, at an affordable price
According to WHO, over 1.5 million people died of TB in 2020
TLD is recommended by WHO, USAID, and PEPFAR as a preferred first-line treatment regimen for the treatment of HIV in adults and pediatric patients weighing at least 35 kg
Subscribe To Our Newsletter & Stay Updated